1L Therapy

CE / CME

Individualizing Frontline Therapy for Patients With Chronic Lymphocytic Leukemia: Putting Evidence Into Practice

Pharmacists: 0.75 contact hour (0.075 CEUs)

Physicians: Maximum of 0.75 AMA PRA Category 1 Credit

Nurses: 0.75 Nursing contact hour

Released: April 19, 2022

Expiration: April 18, 2023

Nichole Fisher
Nichole Fisher, RN, BSN
Anthony J. Perissinotti
Anthony J. Perissinotti, PharmD, BCOP
Jennifer A. Woyach
Jennifer A. Woyach, MD

Activity

Progress
1
Course Completed

In this focused activity, Jennifer Woyach, MD; Nichole Fisher, RN, BSN; and Anthony Perissinotti, PharmD, BCOP, review multidisciplinary best practices in the frontline treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), including important considerations for treatment selection.

Clinical Care Options plans to measure the educational impact of this activity, and some questions will be asked twice: once prior to the discussion that informs the best choice and then again after that specific discussion. Your responses will be aggregated for analysis, but your specific responses will not be shared.

Before continuing with this educational activity, please take a moment to answer the following question.

If you are a practicing healthcare professional, how many patients with CLL do you provide care for in a typical month?

Currently, how confident are you in your ability to individualize optimal therapeutic strategies for patients with CLL based on available data and expert recommendations?